BHC Bausch Health Companies Inc.

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:BHC.

$7.16  -0.15 (-2.05%)
As of 09/27/2022 15:59:49 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  Canada
IPO date:  08/26/2013
Outstanding shares:  360,989,744
Average volume:  11,489,626
Market cap:   $2,541,367,798
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFFVVC1
Valuation   (See tab for details)
PE ratio:   -6.24
PB ratio:   4.68
PS ratio:   0.31
Return on equity:   188.43%
Net income %:   -4.89%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy